Where is Alkermes located?

Alkermes is headquartered in Dublin, Ireland. It is registered at Waltham, Massachusetts.

How many employees does Alkermes have?

As of May 31, 2026, the latest employee count at Alkermes is 2390.

Is Alkermes a funded company?

Alkermes is a funded company, having raised a total of $46M across 6 funding rounds to date. The company's 1st funding round was a $***** Series B round.

When was the latest funding round of Alkermes?

Alkermes' latest funding was a $***** Grant (prize money) round on Sep 30, 2010, with participation from 1 investor.

What is the annual revenue of Alkermes?

Annual revenue of Alkermes is $1.48B as on Dec 31, 2025.

Where does Alkermes rank among its competitors?

Alkermes ranks 105th amongst 2816 active competitors, of which 975 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Karyopharm, which secured $30M in Mar, 2026.

Who are the top competitors of Alkermes?

Alkermes' top competitors include Jazz Pharmaceuticals, Biogen and PTC Therapeutics. Among them, Karyopharm secured the most recent funding round in March, 2026.

Alkermes - 2026 Company Profile, Team, Funding, Competitors & Financials

Alkermes is a public company based in Dublin (Ireland), founded in 1987. It operates as a Developer of small molecule therapeutics and drug delivery technologies for multiple CNS diseases. Alkermes has raised $46M in funding. The company has 2816 active competitors, including 975 funded and 695 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, Biogen and PTC Therapeutics.

Company Details

Developer of small molecule therapeutics and drug delivery technologies for multiple CNS diseases. The company is developing medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction, and multiple sclerosis.

Website: www.alkermes.com/
Registered Address: Waltham, Massachusetts

Key Metrics

Founded Year

1987

Location

Dublin, Ireland

Stage

Public

Total Funding

$46M in 6 rounds

Latest Funding Round

Grant (prize money), Sep 30, 2010, $*****

Investors

Tekla Capital Management & 5 more

Ranked

105^th among 2816 active competitors

Annual Revenue

$1.48B as on Dec 31, 2025

Employee Count

2,390 as on May 31, 2026

Investment & Acquisitions

Avadel Pharmaceuticals & 5 more

Similar Companies

Jazz Pharmaceuticals & 552 more

Exit Details

Public

View Alkermes' full profile

Alkermes is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Alkermes, Inc. CIN: 232472830 , United States, Active	Dec 26, 999	-	1662 (As on Dec 31, 2024)	-
ALKERMES PLC. CIN: 1520262 , United States, Active		$1.48B (As on Dec 31, 2025)	-	-

Alkermes got listed on Jul 16, 1991.

Click here to take a look at Alkermes's IPO in detail

Alkermes has raised a total funding of $46M over 6 rounds. Its latest funding round was a Grant (prize money) round on Sep 30, 2010 for $*****. 1 investor participated in its latest round. Alkermes has 6 institutional investors.

Here is the list of recent funding rounds of Alkermes:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 30, 2010	8408348	Grant (prize money)	1524927	2995400	6535567	7928782
Feb 03, 2005	5501421	Venture Debt	6455631	8847863	2555344	2886959
Aug 19, 2003	7690726	Post IPO	6591278	9669810	2728573	3939404

Access funding benchmarks and valuations. Sign up today!

View details of Alkermes's funding rounds and investors

Alkermes' employee count trend

Alkermes has 2,390 employees as of May 26. Here is Alkermes's employee count trend over the years:

Uncover Alkermes' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Alkermes include Jazz Pharmaceuticals, Biogen and PTC Therapeutics. Here is the list of Top 10 competitors of Alkermes, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jazz Pharmaceuticals 2003, Dublin (Ireland), Public	Developer of novel biopharmaceutical medicines for unmet medical needs	$265M	Versant Ventures, Prospect Venture Partners ... & 14 others	82/100
2nd	Biogen 1978, Cambridge (United States), Public	Developer of therapies for neurodegenerative and immunology disorders	$80M	Berkshire Hathaway, Gershon Capital & 10 others	78/100
3rd	PTC Therapeutics 1998, South Plainfield (United States), Public	Developer of small molecule drugs for the treatment of rare diseases	$248M	HBM Healthcare Investments, Credit Suisse First Boston ... & 27 others	77/100
4th	Sana Biotechnology 2018, Seattle (United States), Public	Developer of engineered cell therapies for treating human disease conditions	$821M	Baillie Gifford, Bezos Expeditions & 17 others	75/100
5th	Blueprint Medicines 2008, Cambridge (United States), Acquired	Developer of selective kinase inhibitors for patients with genomically defined cancers	$115M	Nextech Invest, Third Rock Ventures & 20 others	72/100
6th	Ideaya Biosciences 2015, San Francisco (United States), Public	Developer of oncology-focused precision medicine using molecular diagnostics	$157M	Boxer Capital, BVF Partners & 15 others	72/100
7th	Kronos Bio 2017, San Mateo (United States), Acquired	Developer of small molecule based therapeutics for cancer treatment	$271M	Omega Funds, Vida Ventures & 18 others	72/100
8th	Sutro Biopharma 2003, United States, Public	Developer of antibody-based therapeutics for cancer therapy	$175M	Skyline Ventures, Alta Partners & 17 others	72/100
9th	Syndax 2005, Waltham (United States), Public	Developer of targeted therapies for the treatment of cancer	$198M	Fidelity Investments, Domain Associates & 18 others	72/100
10th	Karyopharm 2008, Natick (United States), Public	Developer of small molecule drugs for the treatment of cancer and inflammatory disease	$98.4M	Foresite Capital, Avidity Partners & 16 others	71/100
105th	Alkermes 1987, Dublin (Ireland), Public	Developer of small molecule therapeutics and drug delivery technologies for multiple CNS diseases	$46M	Tekla Capital Management, Cardinal Partners ... & 4 others	63/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Alkermes's competitors? Click here to see the top ones

Alkermes has made 3 investments in companies including Civitas Therapeutics and Civitas Therapeutics. Alkermes has also acquired 3 companies including Avadel Pharmaceuticals and Rodin Therapeutics.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Oct 22, 2025	Acquisition	Avadel Pharmaceuticals	1990	Dublin (Ireland)
Nov 18, 2019	Acquisition	Rodin Therapeutics	2013	Cambridge (United States)
Aug 29, 2014	Investments	Civitas Therapeutics	2009	Chelsea (United States)